U.S. Food et al., 1953-12-07: FDA application record for oral methotrexate sodium showing an original approval dated 7 December 1953 and Strides Pharma International as current holder.
12/07/1953
HTML record, unpaginated
U.S. Food et al., 1953-12-07: FDA application record for oral methotrexate sodium showing an original approval dated 7 December 1953 and Strides Pharma International as current holder. Funder/conflicts: n/a. Maker: current holder Strides Pharma International; 1953 sponsor (Lederle Laboratories) is not named on the FDA page. Comparator: n/a. A separate injectable NDA (011719, Hospira) also exists. No composition-of-matter patent for methotrexate was located for this run (see Run Notes). Study type: regulatory record.
